I am a
Home I AM A Search Login

Papers of the Week

Papers: 10 Aug 2019 - 16 Aug 2019

Human Studies, Pharmacology/Drug Development


J Pain Res


Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect.


Wu S, Lian Y, Zhang H, Chen Y, Wu C, Li S, Zheng Y, Wang Y, Cheng W, Huang Z
J Pain Res. 2019; 12:2177-2186.
PMID: 31410051.


Some studies have indicated that a local injection of Botulinum Toxin Type A (BTX-A) is a promising therapy for trigeminal neuralgia (TN). However, BTX-A treatment is still ineffective for approximately 10-43% of patients. We therefore investigated which factors are associated with the therapeutic effect in BTX-A treatment of medically refractory, classical TN.